Early Neonatal Meconium Does Not Have a Demonstrable Microbiota Determined through Use of Robust Negative Controls

Scott J Dos Santos1, Zahra Pakzad2,3, Chelsea N Elwood2,4

  • 1Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewangrid.25152.31, Saskatoon, Saskatchewan, Canada.

Microbiology Spectrum
|September 29, 2021
PubMed

Insights

This study found no significant bacterial DNA in neonatal meconium, challenging the in utero colonization theory. Robust controls revealed meconium microbial content indistinguishable from contamination, suggesting colonization begins after birth.

Area of Science:

  • Microbiology
  • Neonatal Research
  • Gut Microbiome Studies

Background:

  • Bacterial DNA in meconium is often cited as evidence for in utero colonization.
  • Previous studies often lack adequate controls for contamination, potentially skewing results.

Purpose of the Study:

  • To accurately define the microbial content of neonatal meconium.
  • To rigorously assess the potential for bacterial colonization in utero.

Main Methods:

  • DNA extraction from 141 meconium samples.
  • cpn60-based microbiome profiling with stringent contamination controls.
  • 16S rRNA quantitative PCR (qPCR) for bacterial load comparison.
  • Bacterial culture and pulsed-field gel electrophoresis (PFGE) for isolate analysis.

Main Results:

  • Meconium samples showed no significant difference in bacterial read numbers or taxonomic composition compared to negative controls.
  • Higher bacterial loads in infant stool versus meconium, which did not differ from sequencing controls.
  • Cultured bacteria were primarily common skin microbes (e.g., Staphylococcus epidermidis), with high diversity.

Conclusions:

  • Robust controls are crucial for low microbial biomass samples like meconium.
  • Findings argue against significant bacterial colonization in utero.
  • Meconium does not harbor a distinct microbiota; observed bacteria likely originate from postnatal exposure.

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...